US Stock MarketDetailed Quotes
EW Edwards Lifesciences
- 86.430
- -1.580-1.80%
Close Apr 26 16:00 ET
- 86.430
- 0.0000.00%
Post 16:44 ET
52.02BMarket Cap37.25P/E (TTM)
88.380High84.710Low4.98MVolume87.000Open88.010Pre Close430.32MTurnover0.84%Turnover Ratio37.58P/E (Static)601.93MShares96.12052wk High7.31P/B51.51BFloat Cap60.57052wk Low--Dividend TTM595.95MShs Float131.730Historical High--Div YieldTTM4.17%Amplitude1.000Historical Low86.410Avg Price1Lot Size
About Edwards Lifesciences Company
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Company Profile
SymbolEW
Company NameEdwards Lifesciences
Listing DateMar 27, 2000
Founded1958
CEOMr. Bernard J. Zovighian
MarketNYSE
Employees19800
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1 Edwards Way
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92614
Phone1-949-250-2500
Websitehttp://www.edwards.com
Company Executives
- Name
- Position
- Salary
- Bernard J. Zovighian
- Director and Chief Executive Officer
- 12.87M
- Scott B. Ullem
- Corporate Vice President and Chief Financial Officer
- 5.95M
- Wayne Markowitz
- General Manager and Senior Vice President, Surgical Structural Heart
- --
- Robert W.A. Sellers
- Senior Vice President, Corporate Controller and Principal Accounting Officer
- --
- Jean-Luc M. Lemercier
- Corporate Vice President, Europe, Middle East, Africa, Canada and Latin America
- 4.34M
- Daniel J. Lippis
- Corporate Vice President, JAPAC
- --
- Catherine M. Szyman
- Corporate Vice President, Critical Care
- 4.34M
- Daveen Chopra
- Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies
- --
- Donald E. Bobo,Jr
- Corporate Vice President
- 4.29M
- Larry L. Wood
- Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart
- 5.40M
- Michael A. Mussallem
- Non-Executive Chairman of the Board
- 1.81M
- Nicholas J. Valeriani
- Independent Director
- 347.97K
- Steven R. Loranger
- Independent Director
- 335.06K
- Ramona Sequeira
- Independent Director
- 334.97K
- Leslie Stone Heisz
- Independent Director
- 356.42K
- Leslie C. Davis
- Independent Director
- --
- Paul A. Laviolette
- Independent Director
- 329.97K
- Martha H. Marsh
- Lead Independent Director
- 364.97K
- Kieran T. Gallahue
- Independent Director
- 335.06K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg